Michael Scanameo, MD
Ophthalmology · Muncie, INNPI 1205819331
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,013 of the $9,166 with a category attached, or 65.6%. 30 manufacturers reported payments, led by AbbVie at 41.7% of the total. Reporting peaked in 2019 at $3,484 and has fallen 66.0% since, to $1,183 in 2025. Among ophthalmology clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 196 payments — averaging $46.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Glaukos Corporation$1K
- Alcon$792
- Johnson & Johnson Surgical Vision, Inc.$409
- Rxsight Inc$385
- Sight Sciences, Inc.$304
- plus $2K from 24 others
What the payments were for
- Consulting fees$2,10023%
- Travel & lodging$94210%
- Food & beverage$6,01366%
- Education$1111%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 33 | $3,819 |
| Glaukos Corporation | 21 | $1,072 |
| Alcon | 32 | $792 |
| Johnson & Johnson Surgical Vision, Inc. | 12 | $409 |
| Rxsight Inc | 8 | $385 |
| Sight Sciences, Inc. | 3 | $304 |
| Bausch & Lomb Americas Inc. | 16 | $286 |
| Harrow Eye, LLC | 3 | $282 |
| Sun Pharmaceutical Industries Inc. | 11 | $198 |
| Coopervision Inc. | 2 | $190 |
| Mallinckrodt Hospital Products Inc. | 6 | $182 |
| Biotissue Holdings Inc. | 3 | $167 |
| Tarsus Pharmaceuticals, Inc. | 3 | $159 |
| Aerie Pharmaceuticals, Inc. | 6 | $134 |
| NEW World Medical,inc. | 8 | $119 |
| Maculogix, Inc. | 1 | $108 |
| Amgen(2 entities) | 6 | $99 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 4 | $81 |
| Eyepoint US, Inc. | 3 | $62 |
| Dompe US, Inc. | 2 | $49 |
| Ivantis, Inc | 3 | $44 |
| Kala Pharmaceuticals, Inc. | 1 | $40 |
| Alimera Sciences, Inc. | 1 | $36 |
| Shire North American Group Inc | 2 | $32 |
| Apellis Pharmaceuticals, Inc. | 1 | $27 |
| Novartis | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $18 |
| Thea Pharma Inc. | 1 | $18 |
| Lensar, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RESTASIS$2,871
- RXSIGHT CONTACT LENS$295
- RXSIGHT INJECTOR CARTRIDGE$295
- RXSIGHT INJECTOR HANDPIECE$295
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$295
- OMNI(R) SURGICAL SYSTEM (US)$283
- IHEEZO$256
- iStent Infinite$222
- iDose$191
- XEN GLAUCOMA TREATMENT SYSTEM$170
- iStent inject Trabecular Micro-Bypass System Model G2-M-IS$165
- iAccess Precision Blade$165
- LIGHT ADJUSTABLE LENS (LAL)$160
- Tecnis Simplicity$144
- SION SURGICAL INSTRUMENT$143
- XEN$141
- RXSIGHT LIGHT ADJUSTABLE LENS (RXLAL)$135
- Rocklatan$122
- Rhopressa$122
- AdaptDx$108
How this compares
$9,166 in reported general payments places this provider in the 90th percentile of 266 ophthalmology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProlensaBromfenac Sodium | 122 | $41,908 |
| Prednisolone Acetate | 471 | $34,013 |
| Ketorolac Tromethamine | 375 | $12,511 |
| LumiganBimatoprost | 15 | $10,798 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 16 | $5,855 |
| VyzultaLatanoprostene Bunod | 13 | $4,619 |
| Cyclosporine | 22 | $4,302 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 459 | $3,773 |
| Bromfenac Sodium | 13 | $2,850 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 15 | $1,764 |
| Timolol Maleate | 58 | $1,112 |
| Latanoprost | 185 | $1,040 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 13 | $540 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 48 | $535 |
| Ofloxacin | 23 | $340 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bausch & Lomb, A Division Of Bausch Health US, LLCProlensa | $81 | $41,908122 claims |
| AbbVieLumigan | $3,819 | $10,79815 claims |
| AlconSimbrinza | $792 | $5,85516 claims |
| Bausch & Lomb Americas Inc.Vyzulta | $286 | $4,61913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 266 ophthalmology providers in Indiana.
Other ophthalmology in Muncie
- Christian BriggsMuncie$5K
- Michael HodkinMuncie$4K
- Shamik BafnaLafayette$505K
- Kevin WaltzIndianapolis$199K
- Janet HummerIndianapolis$96K
- Francis PriceIndianapolis$67K
- Omar DukarEvansville$43K
- Gerald RoperBatesville$34K
- Dwight SilveraEvansville$28K
- Michael OrrIndianapolis$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.